We are live on ! Find out more
FLACW

Frazier Lifesciences Acquisition Corporation Warrant
FLACW

Delisted

FLACW was delisted on the 22nd of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Frazier Lifesciences Acquisition Corporation Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $2.6M → $0 (-$2.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
–
Holders Change
-21
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$698K
2
EC
EcoR1 Capital
California
-$665K
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$126K
4
ETH
Exos TFP Holdings
New York
-$100K
5
SCM
Shaolin Capital Management
Florida
-$88K

FLACW Hedge Fund Activity: Q4 2022 in Review

0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q4 2022, worth a combined $0 — down 100% from $2.6M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of FLACW and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $698K sold.

  • 0 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q4 2022, down from 21 in Q3 2022.
  • Funds reported $0 of Frazier Lifesciences Acquisition Corporation Warrant stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q4 2022 and 21 closed out, a net change of -21 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $698K sold.

Based on aggregated 13F filings for Q4 2022.